ptc therapeutics - Search Videos

Big move for PTC Therapeutics

Big move for PTC Therapeutics

PTC Therapeutics skyrockets on a recommendation for approval in Europe for its Duchenne Muscular Dystrophy drug. CNBC's Meg Tirrell provides insight to the disease and treatment options. Shane Kovacs, PTC Therapeutics CFO, looks at the move in the stock.

CNBCJan 1, 2009

PTC Therapeutics Stock

How A $2.9 Billion Deal Sent This Biotech To The Stratosphere

How A $2.9 Billion Deal Sent This Biotech To The Stratosphere

Sorrento Therapeutics CEO Henry Ji on potential Covid-19 antibody

Sorrento Therapeutics CEO Henry Ji on potential Covid-19 antibody

Jasper Therapeutics Stock Is up 127% in Three Days. How Much Higher Can It Go?

Jasper Therapeutics Stock Is up 127% in Three Days. How Much Higher Can It Go?

Top videos

PTC Therapeutics Becomes Oversold (PTCT)

PTC Therapeutics Becomes Oversold (PTCT)

PTC Therapeutics, Inc.: PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy

PTC Therapeutics, Inc.: PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy

finanznachrichten.de

Industry Solutions for Digital Transformation.. | PTC

Industry Solutions for Digital Transformation.. | PTC

PTC Therapeutics Pipeline

BioLineRx | Discover Our Pipeline

BioLineRx | Discover Our Pipeline

About PTC | PTC

About PTC | PTC

Pipeline for Neurodegenerative Diseases - Alector

Pipeline for Neurodegenerative Diseases - Alector